{
  "ptid_time": "023_S_4502_2016-04-12",
  "img_path": "/data/qiuhui/data/adni/images/023_S_4502/2016-04-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 39,366 mm³, 76.2% above the reference mean. With a Z-score of 1.91 (97.2th percentile), this represents moderate enlargement; hippocampal volume measures 4,366 mm³, 43.2% below the reference mean. With a Z-score of -4.85 (0.0th percentile), this represents profound atrophy; whole brain volume measures 860,767 mm³, 16.4% below the reference mean. With a Z-score of -2.04 (2.1th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,042 mm³, 47.5% below the reference mean. With a Z-score of -3.68 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 13,879 mm³, 23.8% below the reference mean. With a Z-score of -2.68 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 12,394 mm³, 39.6% below the reference mean. With a Z-score of -3.52 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 62.5 years. Gender is Female. Education: 20 years. MMSE: 4.0. MoCA: 1.0. APOEε4 alleles: 2.0. Biomarker levels: Amyloid beta: 609.70 pg/mL (mild reduced); Total tau: 525.70 pg/mL (profound elevated); Phosphorylated tau: 46.73 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, middle temporal gyrus) alongside significant whole-brain atrophy and ventricular enlargement. The clinical profile (severely impaired MMSE/MoCA, APOE4 homozygosity, elevated tau, and reduced Aβ) strongly supports neurodegenerative disease consistent with Alzheimer's pathology.  \n\n**Diagnosis:** Dementia (Alzheimer’s disease)  \n**Confidence:** High",
  "timestamp": "2025-07-26T03:07:33.417585"
}